Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$832,755,921
+$172,264,487 QoQ
Shares Held
694,293
-3.3% QoQ
Ownership
0.074%
of shares outstanding
% of Portfolio
1.29%
of 13F equity value
Holder Rank
#96
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 64%
Shared 0%
None 36%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LAZARD ASSET MANAGEMENT LLC holds $2,100,933,315 across 14 Drug Manufacturers - General names. LLY ranks #1 (39.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
694,293 | $832,755,921 | |
| 2 | AZN |
Astrazeneca PLC
|
2,332,566 | $442,301,164 | |
| 3 | JNJ |
Johnson & Johnson
|
1,364,685 | $346,589,048 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,843,591 | $236,901,443 | |
| 5 | ABBV |
AbbVie Inc.
|
254,499 | $64,042,128 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,063,855 | $61,299,324 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
284,948 | $36,000,330 | |
| 8 | NVO |
Novo Nordisk A S
|
657,641 | $31,527,309 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $832,755,921 | 694,293 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $660,491,434 | 718,105 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $719,951,839 | 669,922 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $827,052,324 | 1,083,948 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $793,482,025 | 1,017,898 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $644,121,426 | 779,893 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $523,455,372 | 678,051 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $137,155,913 | 154,814 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $218,340,533 | 241,159 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $221,021,545 | 284,104 | Shares | Sole | 2024-07-09 | |
| 2023-12-31 | $185,057,279 | 317,466 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $175,086,115 | 325,966 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $157,743,766 | 336,355 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $128,508,105 | 374,201 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $133,549,159 | 365,048 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $120,229,935 | 371,826 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $129,160,259 | 398,360 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $126,444,381 | 441,542 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $142,223,743 | 514,893 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $137,213,430 | 593,869 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $246,053,930 | 1,072,037 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $153,256,664 | 820,344 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $124,097,399 | 735,000 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $109,945,258 | 742,773 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $94,453,080 | 575,302 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $77,311,983 | 557,324 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||